Clinical Read2026-06-30

PH-762

Phio PharmaceuticalsPHIO

Indication
Cutaneous squamous cell carcinoma (cSCC)
Stage
Phase 1b
Event
Phase 1b Data readout
Details

Date not specified — The provided content appears to be a navigation/menu fragment from an investor relations page (“Press Releases,” “Events & Presentations,” “Stock Information,” “Corporate Governance,” “Financial Information,” “Email Alerts”) and does not include any readable press release/article text. No company name, study/trial/product/event details, results, or business announcements are present in the supplied material, so no substantive summary can be generated from it.

Financial Snapshot

Market Cap

$12.7M

Price

$1.08